发明名称 |
ANTI-DLL3 ANTIBODY |
摘要 |
It is intended to disclose an antibody which binds to DLL3 protein. Preferably, the antibody of the present invention recognizes a region from amino acids 216 to 492 in human DLL3 having the amino acid sequence as set forth in SEQ ID NO: 1. The present invention also provides a pharmaceutical composition, for example, an anticancer agent, comprising the antibody of the present invention as an active ingredient. The present invention further discloses a method for diagnosing cancer using the antibody of the present invention and a diagnostic drug for cancer comprising the antibody of the present invention. |
申请公布号 |
EP2530091(A4) |
申请公布日期 |
2013.07.10 |
申请号 |
EP20110736812 |
申请日期 |
2011.01.28 |
申请人 |
FORERUNNER PHARMA RESEARCH CO., LTD.;THE UNIVERSITY OF TOKYO |
发明人 |
YOSHIDA, KENJI;ABURATANI, HIROYUKI;ISHIKAWA, SHUMPEI |
分类号 |
C07K16/30;A61K39/395;A61P35/00;C12N15/02;C12Q1/02;C12Q1/68;G01N33/50;G01N33/574;G01N33/68 |
主分类号 |
C07K16/30 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|